Triaging Pap cytology negative, HPV positive cervical cancer screening results with p16/Ki-67 Dual-stained cytology

Gynecologic Oncology

Volumn 121, Issue 3, 2011, Pages 505-509

  Petry, K Ulrich ^a,h   Schmidt, Dietmar ^b   Scherbring, Sarah ^a   Luyten, Alexander ^a   Reinecke Lüthge, Axel ^a   Bergeron, Christine ^c   Kommoss, Friedrich ^b   Löning, Thomas ^d   Ordi, Jaume ^e   Regauer, Sigrid ^f   Ridder, Ruediger ^g  

^a Klinikum der Stadt Wolfsburg   (Germany)

^b Institute of Pathology   (Germany)

^c LABORATOIRE CERBA   (France)

^d ALBERTINEN KRANKENHAUS   (Germany)

^e UNIVERSITY OF BARCELONA   (Spain)

^f UNIVERSITY OF GRAZ   (Austria)

^g MTM Laboratories   (Germany)

^h Klinikum der Stadt Wolfsburg   (Germany)

Author keywords

Cervical intraepithelial neoplasia; Dual stained cytology; Human papillomavirus, HPV; Ki 67; p16INK4a; Pap cytology

Indexed keywords

KI 67 ANTIGEN; PROTEIN P16;

ADULT; AGED; ARTICLE; CANCER SCREENING; COLPOSCOPY; EXTRACELLULAR FLUID; FEMALE; FOLLOW UP; HUMAN; PAPANICOLAOU TEST; PREDICTIVE VALUE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; UTERINE CERVIX CARCINOMA IN SITU; WART VIRUS;

ADULT; AGED; AGED, 80 AND OVER; CERVICAL INTRAEPITHELIAL NEOPLASIA; COHORT STUDIES; FEMALE; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; NEOPLASM PROTEINS; PAPILLOMAVIRUS INFECTIONS; SENSITIVITY AND SPECIFICITY; STAINING AND LABELING; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 79957472045     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.02.033     Document Type: Article

References (25)

1. J. Cuzick, C. Clavel, and K.U. Petry Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int J Cancer 119 2006 1095 1101 (Pubitemid 44116919)
2. M. Arbyn, G. Ronco, and C.J. Meijer Trials comparing cytology with human papillomavirus screening Lancet Oncol 10 2009 935 936
3. G. Ronco, P. Giorgi-Rossi, F. Carozzi, M. Confortini, P. Dalla Palma, and A. Del Mistro Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomized controlled trial Lancet Oncol 11 2010 249 257
4. J.M. Walboomers, M.V. Jacobs, and M.M. Manos Human papillomavirus is a necessary cause of invasive cervical cancer worldwide J Pathol 189 1999 12 19 (Pubitemid 29406813)
5. C. Liebrich, O. Brummer, and R. von Wasielewski Primary cervical cancer truly negative for high-risk human papillomavirus is a rare but distinct entity that can affect virgins and young adolescents Eur J Gynaecol Oncol 30 2009 45 48
6. S. Kjaer, E. Høgdall, and K. Frederiksen The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive, cytologically normal women over a 10-year period Cancer Res 66 2006 10630 10636 (Pubitemid 44799787)
7. N.W. Bulkmans, J. Berkhof, and L. Rozendaal Human papillomavirus DNA testing for the detection of cervical intraepithelial neoplasia grade 3 and cancer: 5-year follow-up of a randomised controlled implementation trial Lancet 370 2007 1764 1772 (Pubitemid 350137476)
8. G.F. Sawaya Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later Ann Intern Med 148 2008 557 559 (Pubitemid 351665425)
9. P.E. Castle HPV testing for cervical cancer: the good, the bad, and the ugly Nat Rev Clin Oncol 7 2010 364 365
10. K.U. Petry, S. Menton, and M. Menton Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients Br J Cancer 88 2003 1570 1577 (Pubitemid 36713784)
11. P.E. Castle, B. Fetterman, N. Poitras, T. Lorey, R. Shaber, and W. Kinney Five-year experience of human papillomavirus DNA and Papanicolaou test contesting Obstet Gynecol 113 2009 595 600
12. M.J. Thrall, D.K. Russell, M.S. Facik, J.L. Yao, J.N. Warner, and T.A. Bonfiglio High-risk HPV testing in women 30 years or older with negative Papanicolaou tests: initial clinical experience with 18-month follow-up Am J Clin Pathol 133 2010 894 898
13. M. von Knebel Doeberitz New markers for cervical dysplasia to visualise the genomic chaos created by aberrant oncogenic papillomavirus infections Eur J Cancer 38 2002 2229 2242 (Pubitemid 35346464)
14. K. Cuschieri, and N. Wentzensen Human papillomavirus mRNA and p16 detection as biomarkers for the improved diagnosis of cervical neoplasia Cancer Epidemiol Biomarkers Prev 17 2008 2536 2545
15. D. Schmidt, C. Bergeron, KJ. Denton, R. Ridder. p16/Ki-67 Dual-stained Cytology in the Triage of ASC-US and LSIL Pap Cytology: Results from the European Equivocal or Mildly Abnormal Pap Cytology Study (EEMAPS). Cancer Cytopathol, in press. doi:10.1002/cncy.20140.
16. A. Luyten, S. Scherbring, A. Reinecke-Lüthge, B.E. Braun, M. Pietralla, and K. Theiler Risk-adapted primary HPV cervical cancer screening project in Wolfsburg, Germany-experience over 3 years J Clin Virol 46 2009 S5 S10
17. D. Solomon, D. Davey, and R. Kurman The 2001 Bethesda system. Terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119 (Pubitemid 34437346)
18. P. Walker, S. Dexeus, G. De Palo, R. Barrasso, M. Campion, and F. Girardi International terminology of colposcopy: an updated report from the International Federation for Cervical Pathology and Colposcopy Obstet Gynecol 101 2003 175 177 (Pubitemid 36057105)
19. M.H. Mayrand, E. Duarte-Franco, and I. Rodrigues Human papillomavirus versus papanicolaou screening tests for cervical cancer N Engl J Med 357 2007 1579 1588 (Pubitemid 47598400)
20. P. Naucler, W. Ryd, and S. Törnberg Human papillomavirus and papanicolaou tests to screen for cervical cancer N Engl J Med 357 2007 1589 1597 (Pubitemid 47598401)
21. M. Leinonen, P. Nieminen, and L. Kotaniemi-Talonen Age-specific evaluation of primary human papillomavirus screening vs conventional cytology in a randomized setting J Natl Cancer Inst 101 2009 1612 1623
22. H.C. Kitchener, M. Almonte, and C. Thomson HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial Lancet Oncol 10 2009 672 682
23. F. Carozzi, M. Confortini, P. Dalla Palma, A. Del Mistro, A. Gillio-Tos, and L. De Marco Use of p16INK4a overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial Lancet Oncol 9 2008 937 945
24. K.J. Denton, C. Bergeron, and P. Klement The sensitivity and specificity of p16INK4a cytology vs. HPV testing for detecting high-grade cervical disease in the triage of ASC-US and LSIL Pap cytology results Am J Clin Pathol 134 2010 12 21
25. M.H. Stoler Toward objective cervical cancer screening. Maybe the eyes do have it [editorial] Am J Clin Pathol 134 2010 5 6